Michael Kaplan

Davis Polk advised Entera Bio Ltd. on its initial public offering of 1,400,000 ordinary shares and 1,400,000 warrants to purchase up to 700,000 ordinary shares. In addition, Entera Bio Ltd…

Davis Polk advised Kadmon Holdings, Inc. in connection with a $113.2 million offering of 32,022,728 shares of common stock, which included the full exercise of the underwriters’ option to…

Davis Polk advised Valeant Pharmaceuticals International, Inc. in connection with a refinancing transaction pursuant to which its indirect wholly owned subsidiary, Valeant Pharmaceuticals…

Davis Polk advised Israel Chemicals Limited in connection with its 144A/Regulation S notes offering of $600 million aggregate principal amount of 6.375% senior notes due 2038.  Davis…

Davis Polk advised the underwriter in connection with the $56.6 million secondary offering of 2,200,000 shares of common stock of TriState Capital Holdings, Inc. by selling…

Davis Polk is advising General Electric Company on the $11.1 billion merger of GE Transportation and Wabtec Corporation. Under the agreement GE will receive $2.9 billion in cash at…

Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 17,250,000 shares of Class A common stock of Virtu Financial, Inc. for an…

Davis Polk advised the joint global coordinators in connection with the initial public offering of CEVA Logistics AG on the SIX Swiss Exchange and concurrent private placement of…

Davis Polk advised BBA Aviation plc in connection with a debut Rule 144A/Regulation S offering of $500 million aggregate principal amount of 5.375% senior unsecured notes due 2026 by BBA U…

Davis Polk advised the joint book-running managers on a Rule 144A/Regulation S offering by TopBuild Escrow Corp., a wholly owned subsidiary of TopBuild Corp., of $400 million aggregate…